Preptin, another peptide product of the pancreatic beta-cell, is osteogenic in vitro and in vivo

1 Department of Medicine and 2 School of Biological Sciences, University of Auckland, Auckland, New Zealand Submitted 20 December 2005 ; accepted in final form 7 August 2006 Several hormones that regulate nutritional status also impact on bone metabolism. Preptin is a recently isolated 34-amino acid...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology: endocrinology and metabolism 2007-01, Vol.292 (1), p.E117-E122
Hauptverfasser: Cornish, J, Callon, K. E, Bava, U, Watson, M, Xu, X, Lin, J. M, Chan, V. A, Grey, A. B, Naot, D, Buchanan, C. M, Cooper, G. J. S, Reid, I. R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page E122
container_issue 1
container_start_page E117
container_title American journal of physiology: endocrinology and metabolism
container_volume 292
creator Cornish, J
Callon, K. E
Bava, U
Watson, M
Xu, X
Lin, J. M
Chan, V. A
Grey, A. B
Naot, D
Buchanan, C. M
Cooper, G. J. S
Reid, I. R
description 1 Department of Medicine and 2 School of Biological Sciences, University of Auckland, Auckland, New Zealand Submitted 20 December 2005 ; accepted in final form 7 August 2006 Several hormones that regulate nutritional status also impact on bone metabolism. Preptin is a recently isolated 34-amino acid peptide hormone that is cosecreted with insulin and amylin from the pancreatic -cells. Preptin corresponds to Asp 69 -Leu 102 of pro-IGF-II. Increased circulating levels of a pro-IGF-II peptide complexed with IGF-binding protein-2 have been implicated in the high bone mass phenotype observed in patients with chronic hepatitis C infection. We have assessed preptin's activities on bone. Preptin dose-dependently stimulated the proliferation (cell number and DNA synthesis) of primary fetal rat osteoblasts and osteoblast-like cell lines at periphysiological concentrations (>10 –11 M). In addition, thymidine incorporation was stimulated in murine neonatal calvarial organ culture, likely reflecting the proliferation of cells from the osteoblast lineage. Preptin did not affect bone resorption in this model. Preptin induced phosphorylation of p42/p44 MAP kinases in osteoblastic cells in a dose-dependent manner (10 –8 -10 –10 M), and its proliferative effects on primary osteoblasts were blocked by MAP kinase kinase inhibitors. Preptin also reduced osteoblast apoptosis induced by serum deprivation, reducing the number of apoptotic cells by >20%. In vivo administration of preptin increased bone area and mineralizing surface in adult mice. These data demonstrate that preptin, which is cosecreted from the pancreatic -cell with amylin and insulin, is anabolic to bone and may contribute to the preservation of bone mass observed in hyperinsulinemic states such as obesity. osteoblast; bone-active hormone; bone anabolic Address for reprint requests and other correspondence: J. Cornish, Dept. of Medicine, Univ. of Auckland, Private Bag 92019, Auckland, NZ (e-mail: j.cornish{at}auckland.ac.nz )
doi_str_mv 10.1152/ajpendo.00642.2005
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_16912056</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68389430</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-1e4deb0fafc139efe0732ab672a89379db1dcb10ff181a091eb7c11b0febdf913</originalsourceid><addsrcrecordid>eNqFkU9PGzEQxa2KqqS0X6CHyidObOrx_vURISiVkNoDPbtee5wYbdaL7QXy7euQIE6IkzWe93t6mkfIN2BLgJr_UHcTjsYvGWsqvuSM1R_IIi94AXVdH5EFA1EW0FXimHyO8Y4x1tYV_0SOoRHAWd0syL8_AafkxjOqRp_WGOi0mw3SKXgz60S9pfmfTmrUAVVymvaYVKFxGM6oi9THhH6FY164kT64FHz2MvvhwX8hH60aIn49vCfk79Xl7cV1cfP756-L85tCV5ylArAy2DOrrIZSoEXWllz1TctVJ8pWmB6M7oFZCx0oJgD7VgNkAntjBZQn5HTvm3PfzxiT3Li4C6lG9HOUTVd2oirZu0IQbce7hmch3wt18DEGtHIKbqPCVgKTuwLkoQD5XIDcFZCh7wf3ud-geUUOF88CsRes3Wr96ALKab2Nzg9-tZVX8zDc4lN6ceaCS5CXAK2cjM1s8Tb7EuaVKf8D8EKpbQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19782862</pqid></control><display><type>article</type><title>Preptin, another peptide product of the pancreatic beta-cell, is osteogenic in vitro and in vivo</title><source>MEDLINE</source><source>American Physiological Society</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Cornish, J ; Callon, K. E ; Bava, U ; Watson, M ; Xu, X ; Lin, J. M ; Chan, V. A ; Grey, A. B ; Naot, D ; Buchanan, C. M ; Cooper, G. J. S ; Reid, I. R</creator><creatorcontrib>Cornish, J ; Callon, K. E ; Bava, U ; Watson, M ; Xu, X ; Lin, J. M ; Chan, V. A ; Grey, A. B ; Naot, D ; Buchanan, C. M ; Cooper, G. J. S ; Reid, I. R</creatorcontrib><description>1 Department of Medicine and 2 School of Biological Sciences, University of Auckland, Auckland, New Zealand Submitted 20 December 2005 ; accepted in final form 7 August 2006 Several hormones that regulate nutritional status also impact on bone metabolism. Preptin is a recently isolated 34-amino acid peptide hormone that is cosecreted with insulin and amylin from the pancreatic -cells. Preptin corresponds to Asp 69 -Leu 102 of pro-IGF-II. Increased circulating levels of a pro-IGF-II peptide complexed with IGF-binding protein-2 have been implicated in the high bone mass phenotype observed in patients with chronic hepatitis C infection. We have assessed preptin's activities on bone. Preptin dose-dependently stimulated the proliferation (cell number and DNA synthesis) of primary fetal rat osteoblasts and osteoblast-like cell lines at periphysiological concentrations (&gt;10 –11 M). In addition, thymidine incorporation was stimulated in murine neonatal calvarial organ culture, likely reflecting the proliferation of cells from the osteoblast lineage. Preptin did not affect bone resorption in this model. Preptin induced phosphorylation of p42/p44 MAP kinases in osteoblastic cells in a dose-dependent manner (10 –8 -10 –10 M), and its proliferative effects on primary osteoblasts were blocked by MAP kinase kinase inhibitors. Preptin also reduced osteoblast apoptosis induced by serum deprivation, reducing the number of apoptotic cells by &gt;20%. In vivo administration of preptin increased bone area and mineralizing surface in adult mice. These data demonstrate that preptin, which is cosecreted from the pancreatic -cell with amylin and insulin, is anabolic to bone and may contribute to the preservation of bone mass observed in hyperinsulinemic states such as obesity. osteoblast; bone-active hormone; bone anabolic Address for reprint requests and other correspondence: J. Cornish, Dept. of Medicine, Univ. of Auckland, Private Bag 92019, Auckland, NZ (e-mail: j.cornish{at}auckland.ac.nz )</description><identifier>ISSN: 0193-1849</identifier><identifier>EISSN: 1522-1555</identifier><identifier>DOI: 10.1152/ajpendo.00642.2005</identifier><identifier>PMID: 16912056</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Bone Development - drug effects ; Cell Differentiation - drug effects ; Cell Proliferation - drug effects ; Cell Survival - drug effects ; Cells, Cultured ; Humans ; Insulin-Like Growth Factor II - metabolism ; Insulin-Like Growth Factor II - pharmacology ; Insulin-Secreting Cells - metabolism ; Male ; Mice ; Mitogen-Activated Protein Kinase 1 - metabolism ; Mitogen-Activated Protein Kinase 3 - metabolism ; Osteoblasts - cytology ; Osteoblasts - drug effects ; Osteoclasts - metabolism ; Osteogenesis - drug effects ; Peptide Fragments - metabolism ; Peptide Fragments - pharmacology ; Peptides - metabolism ; Peptides - pharmacology ; Pertussis Toxin - pharmacology ; Rats ; Receptors, Islet Amyloid Polypeptide ; Receptors, Peptide - antagonists &amp; inhibitors ; Swiss 3T3 Cells</subject><ispartof>American journal of physiology: endocrinology and metabolism, 2007-01, Vol.292 (1), p.E117-E122</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c420t-1e4deb0fafc139efe0732ab672a89379db1dcb10ff181a091eb7c11b0febdf913</citedby><cites>FETCH-LOGICAL-c420t-1e4deb0fafc139efe0732ab672a89379db1dcb10ff181a091eb7c11b0febdf913</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,3026,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16912056$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cornish, J</creatorcontrib><creatorcontrib>Callon, K. E</creatorcontrib><creatorcontrib>Bava, U</creatorcontrib><creatorcontrib>Watson, M</creatorcontrib><creatorcontrib>Xu, X</creatorcontrib><creatorcontrib>Lin, J. M</creatorcontrib><creatorcontrib>Chan, V. A</creatorcontrib><creatorcontrib>Grey, A. B</creatorcontrib><creatorcontrib>Naot, D</creatorcontrib><creatorcontrib>Buchanan, C. M</creatorcontrib><creatorcontrib>Cooper, G. J. S</creatorcontrib><creatorcontrib>Reid, I. R</creatorcontrib><title>Preptin, another peptide product of the pancreatic beta-cell, is osteogenic in vitro and in vivo</title><title>American journal of physiology: endocrinology and metabolism</title><addtitle>Am J Physiol Endocrinol Metab</addtitle><description>1 Department of Medicine and 2 School of Biological Sciences, University of Auckland, Auckland, New Zealand Submitted 20 December 2005 ; accepted in final form 7 August 2006 Several hormones that regulate nutritional status also impact on bone metabolism. Preptin is a recently isolated 34-amino acid peptide hormone that is cosecreted with insulin and amylin from the pancreatic -cells. Preptin corresponds to Asp 69 -Leu 102 of pro-IGF-II. Increased circulating levels of a pro-IGF-II peptide complexed with IGF-binding protein-2 have been implicated in the high bone mass phenotype observed in patients with chronic hepatitis C infection. We have assessed preptin's activities on bone. Preptin dose-dependently stimulated the proliferation (cell number and DNA synthesis) of primary fetal rat osteoblasts and osteoblast-like cell lines at periphysiological concentrations (&gt;10 –11 M). In addition, thymidine incorporation was stimulated in murine neonatal calvarial organ culture, likely reflecting the proliferation of cells from the osteoblast lineage. Preptin did not affect bone resorption in this model. Preptin induced phosphorylation of p42/p44 MAP kinases in osteoblastic cells in a dose-dependent manner (10 –8 -10 –10 M), and its proliferative effects on primary osteoblasts were blocked by MAP kinase kinase inhibitors. Preptin also reduced osteoblast apoptosis induced by serum deprivation, reducing the number of apoptotic cells by &gt;20%. In vivo administration of preptin increased bone area and mineralizing surface in adult mice. These data demonstrate that preptin, which is cosecreted from the pancreatic -cell with amylin and insulin, is anabolic to bone and may contribute to the preservation of bone mass observed in hyperinsulinemic states such as obesity. osteoblast; bone-active hormone; bone anabolic Address for reprint requests and other correspondence: J. Cornish, Dept. of Medicine, Univ. of Auckland, Private Bag 92019, Auckland, NZ (e-mail: j.cornish{at}auckland.ac.nz )</description><subject>Animals</subject><subject>Bone Development - drug effects</subject><subject>Cell Differentiation - drug effects</subject><subject>Cell Proliferation - drug effects</subject><subject>Cell Survival - drug effects</subject><subject>Cells, Cultured</subject><subject>Humans</subject><subject>Insulin-Like Growth Factor II - metabolism</subject><subject>Insulin-Like Growth Factor II - pharmacology</subject><subject>Insulin-Secreting Cells - metabolism</subject><subject>Male</subject><subject>Mice</subject><subject>Mitogen-Activated Protein Kinase 1 - metabolism</subject><subject>Mitogen-Activated Protein Kinase 3 - metabolism</subject><subject>Osteoblasts - cytology</subject><subject>Osteoblasts - drug effects</subject><subject>Osteoclasts - metabolism</subject><subject>Osteogenesis - drug effects</subject><subject>Peptide Fragments - metabolism</subject><subject>Peptide Fragments - pharmacology</subject><subject>Peptides - metabolism</subject><subject>Peptides - pharmacology</subject><subject>Pertussis Toxin - pharmacology</subject><subject>Rats</subject><subject>Receptors, Islet Amyloid Polypeptide</subject><subject>Receptors, Peptide - antagonists &amp; inhibitors</subject><subject>Swiss 3T3 Cells</subject><issn>0193-1849</issn><issn>1522-1555</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU9PGzEQxa2KqqS0X6CHyidObOrx_vURISiVkNoDPbtee5wYbdaL7QXy7euQIE6IkzWe93t6mkfIN2BLgJr_UHcTjsYvGWsqvuSM1R_IIi94AXVdH5EFA1EW0FXimHyO8Y4x1tYV_0SOoRHAWd0syL8_AafkxjOqRp_WGOi0mw3SKXgz60S9pfmfTmrUAVVymvaYVKFxGM6oi9THhH6FY164kT64FHz2MvvhwX8hH60aIn49vCfk79Xl7cV1cfP756-L85tCV5ylArAy2DOrrIZSoEXWllz1TctVJ8pWmB6M7oFZCx0oJgD7VgNkAntjBZQn5HTvm3PfzxiT3Li4C6lG9HOUTVd2oirZu0IQbce7hmch3wt18DEGtHIKbqPCVgKTuwLkoQD5XIDcFZCh7wf3ud-geUUOF88CsRes3Wr96ALKab2Nzg9-tZVX8zDc4lN6ceaCS5CXAK2cjM1s8Tb7EuaVKf8D8EKpbQ</recordid><startdate>20070101</startdate><enddate>20070101</enddate><creator>Cornish, J</creator><creator>Callon, K. E</creator><creator>Bava, U</creator><creator>Watson, M</creator><creator>Xu, X</creator><creator>Lin, J. M</creator><creator>Chan, V. A</creator><creator>Grey, A. B</creator><creator>Naot, D</creator><creator>Buchanan, C. M</creator><creator>Cooper, G. J. S</creator><creator>Reid, I. R</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TM</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20070101</creationdate><title>Preptin, another peptide product of the pancreatic beta-cell, is osteogenic in vitro and in vivo</title><author>Cornish, J ; Callon, K. E ; Bava, U ; Watson, M ; Xu, X ; Lin, J. M ; Chan, V. A ; Grey, A. B ; Naot, D ; Buchanan, C. M ; Cooper, G. J. S ; Reid, I. R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-1e4deb0fafc139efe0732ab672a89379db1dcb10ff181a091eb7c11b0febdf913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Animals</topic><topic>Bone Development - drug effects</topic><topic>Cell Differentiation - drug effects</topic><topic>Cell Proliferation - drug effects</topic><topic>Cell Survival - drug effects</topic><topic>Cells, Cultured</topic><topic>Humans</topic><topic>Insulin-Like Growth Factor II - metabolism</topic><topic>Insulin-Like Growth Factor II - pharmacology</topic><topic>Insulin-Secreting Cells - metabolism</topic><topic>Male</topic><topic>Mice</topic><topic>Mitogen-Activated Protein Kinase 1 - metabolism</topic><topic>Mitogen-Activated Protein Kinase 3 - metabolism</topic><topic>Osteoblasts - cytology</topic><topic>Osteoblasts - drug effects</topic><topic>Osteoclasts - metabolism</topic><topic>Osteogenesis - drug effects</topic><topic>Peptide Fragments - metabolism</topic><topic>Peptide Fragments - pharmacology</topic><topic>Peptides - metabolism</topic><topic>Peptides - pharmacology</topic><topic>Pertussis Toxin - pharmacology</topic><topic>Rats</topic><topic>Receptors, Islet Amyloid Polypeptide</topic><topic>Receptors, Peptide - antagonists &amp; inhibitors</topic><topic>Swiss 3T3 Cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cornish, J</creatorcontrib><creatorcontrib>Callon, K. E</creatorcontrib><creatorcontrib>Bava, U</creatorcontrib><creatorcontrib>Watson, M</creatorcontrib><creatorcontrib>Xu, X</creatorcontrib><creatorcontrib>Lin, J. M</creatorcontrib><creatorcontrib>Chan, V. A</creatorcontrib><creatorcontrib>Grey, A. B</creatorcontrib><creatorcontrib>Naot, D</creatorcontrib><creatorcontrib>Buchanan, C. M</creatorcontrib><creatorcontrib>Cooper, G. J. S</creatorcontrib><creatorcontrib>Reid, I. R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of physiology: endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cornish, J</au><au>Callon, K. E</au><au>Bava, U</au><au>Watson, M</au><au>Xu, X</au><au>Lin, J. M</au><au>Chan, V. A</au><au>Grey, A. B</au><au>Naot, D</au><au>Buchanan, C. M</au><au>Cooper, G. J. S</au><au>Reid, I. R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Preptin, another peptide product of the pancreatic beta-cell, is osteogenic in vitro and in vivo</atitle><jtitle>American journal of physiology: endocrinology and metabolism</jtitle><addtitle>Am J Physiol Endocrinol Metab</addtitle><date>2007-01-01</date><risdate>2007</risdate><volume>292</volume><issue>1</issue><spage>E117</spage><epage>E122</epage><pages>E117-E122</pages><issn>0193-1849</issn><eissn>1522-1555</eissn><abstract>1 Department of Medicine and 2 School of Biological Sciences, University of Auckland, Auckland, New Zealand Submitted 20 December 2005 ; accepted in final form 7 August 2006 Several hormones that regulate nutritional status also impact on bone metabolism. Preptin is a recently isolated 34-amino acid peptide hormone that is cosecreted with insulin and amylin from the pancreatic -cells. Preptin corresponds to Asp 69 -Leu 102 of pro-IGF-II. Increased circulating levels of a pro-IGF-II peptide complexed with IGF-binding protein-2 have been implicated in the high bone mass phenotype observed in patients with chronic hepatitis C infection. We have assessed preptin's activities on bone. Preptin dose-dependently stimulated the proliferation (cell number and DNA synthesis) of primary fetal rat osteoblasts and osteoblast-like cell lines at periphysiological concentrations (&gt;10 –11 M). In addition, thymidine incorporation was stimulated in murine neonatal calvarial organ culture, likely reflecting the proliferation of cells from the osteoblast lineage. Preptin did not affect bone resorption in this model. Preptin induced phosphorylation of p42/p44 MAP kinases in osteoblastic cells in a dose-dependent manner (10 –8 -10 –10 M), and its proliferative effects on primary osteoblasts were blocked by MAP kinase kinase inhibitors. Preptin also reduced osteoblast apoptosis induced by serum deprivation, reducing the number of apoptotic cells by &gt;20%. In vivo administration of preptin increased bone area and mineralizing surface in adult mice. These data demonstrate that preptin, which is cosecreted from the pancreatic -cell with amylin and insulin, is anabolic to bone and may contribute to the preservation of bone mass observed in hyperinsulinemic states such as obesity. osteoblast; bone-active hormone; bone anabolic Address for reprint requests and other correspondence: J. Cornish, Dept. of Medicine, Univ. of Auckland, Private Bag 92019, Auckland, NZ (e-mail: j.cornish{at}auckland.ac.nz )</abstract><cop>United States</cop><pmid>16912056</pmid><doi>10.1152/ajpendo.00642.2005</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0193-1849
ispartof American journal of physiology: endocrinology and metabolism, 2007-01, Vol.292 (1), p.E117-E122
issn 0193-1849
1522-1555
language eng
recordid cdi_pubmed_primary_16912056
source MEDLINE; American Physiological Society; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Animals
Bone Development - drug effects
Cell Differentiation - drug effects
Cell Proliferation - drug effects
Cell Survival - drug effects
Cells, Cultured
Humans
Insulin-Like Growth Factor II - metabolism
Insulin-Like Growth Factor II - pharmacology
Insulin-Secreting Cells - metabolism
Male
Mice
Mitogen-Activated Protein Kinase 1 - metabolism
Mitogen-Activated Protein Kinase 3 - metabolism
Osteoblasts - cytology
Osteoblasts - drug effects
Osteoclasts - metabolism
Osteogenesis - drug effects
Peptide Fragments - metabolism
Peptide Fragments - pharmacology
Peptides - metabolism
Peptides - pharmacology
Pertussis Toxin - pharmacology
Rats
Receptors, Islet Amyloid Polypeptide
Receptors, Peptide - antagonists & inhibitors
Swiss 3T3 Cells
title Preptin, another peptide product of the pancreatic beta-cell, is osteogenic in vitro and in vivo
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T03%3A33%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Preptin,%20another%20peptide%20product%20of%20the%20pancreatic%20beta-cell,%20is%20osteogenic%20in%20vitro%20and%20in%20vivo&rft.jtitle=American%20journal%20of%20physiology:%20endocrinology%20and%20metabolism&rft.au=Cornish,%20J&rft.date=2007-01-01&rft.volume=292&rft.issue=1&rft.spage=E117&rft.epage=E122&rft.pages=E117-E122&rft.issn=0193-1849&rft.eissn=1522-1555&rft_id=info:doi/10.1152/ajpendo.00642.2005&rft_dat=%3Cproquest_pubme%3E68389430%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19782862&rft_id=info:pmid/16912056&rfr_iscdi=true